Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Product sales, net	$ 2,360,117	$ 2,513,805	$ 6,916,003	$ 6,616,414
Cost of products sold	719,247	677,585	2,010,092	1,692,888
Gross profit	1,640,870	1,836,220	4,905,911	4,923,526
Selling, general and administrative expenses	2,739,011	3,064,769	9,026,691	8,968,226
Research and development expenses	16,226	232,056	437,135	641,235
Depreciation and amortization expense	20,104	8,574	59,040	28,735
Total operating expenses	2,775,341	3,305,399	9,522,866	9,638,196
Loss from operations	(1,134,471)	(1,469,179)	(4,616,955)	(4,714,670)
Interest (expense) income, net	(19,488)	8,008	(14,700)	53,513
Gain on sale of net operating losses				1,983,095
Loss before provision for income taxes	(1,153,959)	(1,461,171)	(4,631,655)	(2,678,062)
Provision for income taxes
Net loss	$ (1,153,959)	$ (1,461,171)	$ (4,631,655)	$ (2,678,062)
Net loss per share applicable to common stockholders - basic	$ (0.01)	$ (0.02)	$ (0.06)	$ (0.03)
Net loss per share applicable to common stockholders - diluted	$ (0.01)	$ (0.02)	$ (0.06)	$ (0.03)
Weighted average shares outstanding and to be issued - basic	82,322,910	79,966,833	82,008,336	80,165,181
Weighted average shares outstanding and to be issued - diluted	82,322,910	79,966,833	82,008,336	80,165,181